Hofseth BioCare ASA (0Q6H.L)

8.04 +8.04 (-77.53%) At close: 02:20PM GMT

Hofseth BioCare ASA

Kipervikgata 13
Ålesund 6003
Norway
47 73 10 22 00
https://www.hofsethbiocare.no

Sector(s): 
Industry: 
Full-time employees: 63

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jon Olav Odegard	Chief Exec. Officer	1.7M	N/A	N/A
Mr. Karl Inge Slotsvik	Chief Operating Officer	1.2M	N/A	N/A
Dr. Bomi Framroze	Chief Scientific Officer	21.73M	N/A	1961
Mr. James Berger	Chief Commercial Officer	7.81M	N/A	N/A
Angelika Florvaag	Chief Quality Officer	822k	N/A	N/A
Dr. Crawford Currie	Head of Medical R&D and Director	N/A	N/A	N/A
Dr. Tanja Schaffer	EVP of Global Ingredients Division & CEO of HBC Switzerland GmbH	N/A	N/A	N/A
Mr. Matt Mixter	Managing Partner of Hofseth North America	N/A	N/A	1984
Dr. Olav Flaten	Exec.	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.

Description

Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.

Corporate governance

Hofseth BioCare ASA’s ISS governance QualityScore as of 28 November 2022 is 5. The pillar scores are Audit: 10; Board: 3; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.